Email Michael Daniels

Mirati Therapeutics, Inc. (NASDAQ:MRTX) Investor Alert: Investigation over Possible Breaches of Fiduciary Duties

Certain directors of Mirati Therapeutics, Inc are under investigation over potential breaches of fiduciary duties.

View full press release

  • We respects your privacy, the information you entered above will not be used to send unsolicited email, and will not be rented or sold to a 3rd party. Your contact information will be shared with the recipient of this message - Privacy Policy